Cite
HARVARD Citation
Le Gars, M. et al. (n.d.). LB7. Ad26.COV2.S-Elicted Neutralizing Activities Against SARS-CoV-2 Variants of Concern in Phase 1/2a and Phase 3 Clinical Trials. Open forum infectious diseases. pp. S804-S805. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Le Gars, M. et al. (n.d.). LB7. Ad26.COV2.S-Elicted Neutralizing Activities Against SARS-CoV-2 Variants of Concern in Phase 1/2a and Phase 3 Clinical Trials. Open forum infectious diseases. pp. S804-S805. [Online].